<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Analysis of Expression Profiles to Elucidate Pathogenic Mechanisms of Temporal Lobe Epilepsy with Hippocampal Sclerosis by Sam Jose</title>
      <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7</link>
      <description></description>
      <language>en-us</language>
      <pubDate>2022-12-02 20:45:11 UTC</pubDate>
      <lastBuildDate>2022-12-04 05:28:46 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>Future Directions</title>
         <author>jys011006</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407145539</link>
         <description><![CDATA[<ul><li>The authors successfully identified 3 differentially expressed signatures in TLE+HS patients. However, expression profiling on larger samples should be performed later on to validate their findings. Further investigations should also focus on the underlying mechanism of the 3 signatures of the disease.&nbsp;</li><li>Among the 3 signatures, FGFR3 might be a more critical focus for future studies. Multiple studies have revealed that there is a non-causal correlation between mutations in FGFR3 and diseases led by impaired temporal lobe function, including epilepsy. For example, Bernardo <em>et al.</em> reported three cases of temporal lobe malfunction with focal epilepsy patients having FGFR3 mutations.<sup>4</sup></li><li>To investigate how FGFR3 is associated with TLE+HS, an experiment that traces the development of temporal lobe epilepsy in the hippocampus kindling model of TLE<sup>5</sup> after regulating FGFR3 expression level by methylation might be a practicable approach. The hippocampus kindling model of TLE is a classic model and the most widely used model in current TLE studies.<sup>5</sup> Another study focusing on epigenetics has successfully inhibited the development of TLE by inhibiting histone deacetylation with this model.<sup>6</sup> If the upregulation of FGFR3 can inhibit or slow down the progression of temporal lobe epilepsy, it could become a potential target for future gene therapy.&nbsp;</li></ul>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1905510589/49e963660d66a12be1f816ba88233c36/image.png" />
         <pubDate>2022-12-02 20:49:51 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407145539</guid>
      </item>
      <item>
         <title>Discussion: Major Findings</title>
         <author>jys011006</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407146516</link>
         <description><![CDATA[<div><strong>The development of TLE+HS might be associated with:</strong></div><ul><li>FGFR3, has-miR-486-5p, and lnc-KCNH5-1&nbsp;</li><li>Pathways associated with Olfactory transduction, Cytokine-cytokine receptor interaction, Oxidative phosphorylation, and Parkinson’s disease</li></ul>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1905510589/6c2e2bb0581291890123d368fc213728/Screen_Shot_2022_12_04_at_12_21_13_AM.png" />
         <pubDate>2022-12-02 20:51:10 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407146516</guid>
      </item>
      <item>
         <title>Strengths &amp; Weaknesses</title>
         <author>jys011006</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407150601</link>
         <description><![CDATA[<div><strong>Strengths&nbsp;</strong></div><ul><li>First to perform a comprehensive expression profile analysis on mRNA, miRNA, and lncRNA in TLE+HS patients</li><li>Supportive evidence from previous studies for the findings</li></ul><div><br><strong>Limitations</strong></div><ul><li>Even with the high sensitivity of microarray, the researchers failed to rule out the false negative rate due to the small sample size</li><li>Methylation was the only epigenetic modifier studied</li><li>Does not determine if the differential expression of signatures is causative for TLE+HS development</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2022-12-02 20:57:19 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407150601</guid>
      </item>
      <item>
         <title>Goal of the Study</title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407171788</link>
         <description><![CDATA[<ul><li>To investigate the potential pathogenic mechanisms of TLE+HS by analyzing the expression profiles of microRNA/mRNA/lncRNA/DNA methylation in brain tissue<sup>2</sup></li><li>Elucidation of a mechanism of action may suggest potential therapeutic targets that can lead to the development of a novel cure</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2022-12-02 21:31:51 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407171788</guid>
      </item>
      <item>
         <title>Differentially Expressed Signatures Between Patients With TLS+HS and Normal Temporal or Parietal Cortices</title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407173658</link>
         <description><![CDATA[<ul><li>The first objective of the authors was to find epigenetic signatures that were differentially expressed between individuals with TLE+HS and NTPs&nbsp;</li><li>A total of 30 miRNAs, 1,908 genes, and 4,010 lncRNAs were found to be differentially expressed with a p-value less than 0.05 indicating statistical significance (Fig. 1)</li><li>The BrainScan database was used for filtering and revealed 11 miRNAs, 592 genes, and 1,028 lncRNAs were differentially expressed between patients with TLE+HS and NTP in comparison to the signatures that were not differentially expressed in normal human hippocampus and cortex database (Fig. 1)</li><li>A total of 116 miRNA-gene co-expression pairs &amp; 224 lncRNA-miRNA co-expression pairs were identified after further correlational and target analysis (Fig. 2)</li></ul>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1905527446/f23c21aef5df103816d3ae269d1836cc/image.png" />
         <pubDate>2022-12-02 21:35:07 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407173658</guid>
      </item>
      <item>
         <title>A Brief Introduction to the Methods: Expression Profiling &amp; Functional Analysis</title>
         <author>jys011006</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407174487</link>
         <description><![CDATA[<div>Sample Collection</div><ul><li>Experimental group: the hippocampal tissue of 6 patients with TLE+HS</li><li>Control: NTPs of 9 patients undergoing internal decompression for traumatic brain injury</li></ul><div>DNA &amp; RNA profiling</div><ul><li>Human microRNA Microarray: miRNA profiling</li><li>lncRNA + mRNA Human Gene Expression Microarray: mRNA &amp; lncRNA profiling</li><li>Illumina 450K Infinitum Methylation BeadChip: DNA methylation detection</li></ul><div>Functional Analysis</div><ul><li>Gene Ontology Analysis: predicting the potential pathological mechanism of TLE+HS</li><li>Gene Set Enrichment Analysis (GSEA): revealing the association between the signatures and the disease phenotype</li></ul>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1905510589/768603471dbc7f3b11e226fccf01912c/fnins_16_892022_g001.jpg" />
         <pubDate>2022-12-02 21:36:21 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407174487</guid>
      </item>
      <item>
         <title>What is Epilepsy?</title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407179993</link>
         <description><![CDATA[<ul><li>Epilepsies are a class of neurological disorders where abnormal brain activity can result in seizures or other unusual behavior such as loss of muscle control &amp; consciousness<sup>1</sup></li><li>Temporal Lobe Epilepsy (TLE) is a type of epilepsy that affects the Temporal Lobe in the patient's brain, which is relevant for auditory processing and memory encoding<sup>2</sup>. Hippocampal Sclerosis (HS) is the loss of neurons in the hippocampus resulting in changes in nearby brain structures<sup>2</sup></li><li>TLE can be idiopathic or caused by traumatic brain injury, infection, genetic disorders, etc<sup>2</sup></li><li>Consequences include cell death via excitotoxicity, physical injuries, and psychological disorders like depression and anxiety<sup>2</sup></li><li>TLE + HS is the most common TLE (70-80%)<sup>2</sup></li><li>TLE + HS is resistant to drug treatment so therapeutic interventions are limited<sup>2</sup></li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2022-12-02 21:46:27 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407179993</guid>
      </item>
      <item>
         <title>What are Epigenetics?</title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407180203</link>
         <description><![CDATA[<ul><li>Epigenetic factors are the modifications in gene expression not directly caused by changes in the genetic code<sup>3</sup></li><li>These modifications are tissue-specific, allowing for the same genetic code in all cells but the differential expression in different tissues allowing for unique biological functions in different cells<sup>3</sup></li><li>Wang <em>et al.</em>, compared differential expression of mRNAs, microRNAs (miRNAs), Long-Non-CodingRNAs (lncRNA), and DNA methylation in the brain tissues of individuals with TLE+HS compared to normal temporal patients (NTPs)<sup>2</sup></li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2022-12-02 21:46:47 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407180203</guid>
      </item>
      <item>
         <title>Gene Ontology and Pathway Analysis of Differential Expressed Signatures</title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407181666</link>
         <description><![CDATA[<ul><li>Gene Ontology and Pathway analysis revealed a significant increase in the differential expression of signatures related to leukocyte migration, the external side of the plasma membrane, and receptor-ligand activity (Fig. 3a)</li><li>A significant increase in the differential expression of signatures related to Cytokine-cytokine receptor interaction was also observed (Fig. 3b)</li><li>These differential expressed signatures may be due to differences in cell populations between the tested groups</li><li>A GSEA was used to demonstrate increased microglia and astrocytes which indicated the differential expression of mRNA was due to differences in cell populations (Fig. 3c)</li></ul>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1905527446/3b0e09a6785d7dcd932cf4054201c56f/fnins_16_892022_g003.jpg" />
         <pubDate>2022-12-02 21:49:27 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407181666</guid>
      </item>
      <item>
         <title>Global DNA Methylation Analysis</title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407181985</link>
         <description><![CDATA[<ul><li>The authors found that six genes were hypomethylated in TLE+HS</li><li>They also found that FGFR3 was the most severely hypomethylated and also highly expressed in TLE+HS</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2022-12-02 21:49:56 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407181985</guid>
      </item>
      <item>
         <title>Validation of the Expression of the Critical mRNAs</title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407182214</link>
         <description><![CDATA[<ul><li>To validate studies, researchers used a validation cohort of 15 patients with TLE+HS and 5 NTPs</li><li>Both studies demonstrated that FGFR3 was highly expressed in patients with TLE+HS</li><li>Results suggested that there was no difference in the expression of FGFR3, has-miR-486-5p, and lnc-KCNH5-1 between the normal hippocampus and the temporal or parietal cortices from NTPs</li><li>This indicated that the differential expression of the FGFR3, has-miR-486-5p, and lnc-KCNH5-1 between hippocampal tissue from patients with TLE+HS and cortical tissue from NTP was not due to tissue site differences</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2022-12-02 21:50:28 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407182214</guid>
      </item>
      <item>
         <title>Function Prediction of FGFR3, Has-miR-486-5p, and lnc-KCNH5-1</title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407182405</link>
         <description><![CDATA[<ul><li>The Gene Set Enrichment Analysis (GSEA) was performed using gene correlation coefficients of&nbsp; FGFR3, has-miR-486-5p,lnc-KCNH5-1 against all genes</li><li>It showed that Olfactory transduction, Cytokine-cytokine receptor interaction, Oxidative phosphorylation, and Parkinson’s disease were associated with expression levels of these signatures&nbsp;</li></ul>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1905527446/11f1cc5d38300bd7d13414a3ba6b6e60/image.png" />
         <pubDate>2022-12-02 21:50:53 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407182405</guid>
      </item>
      <item>
         <title>Significance</title>
         <author>jys011006</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407192161</link>
         <description><![CDATA[<div><strong>How are the 3 signatures related to TLE+HS?</strong><br>FGFR3</div><ul><li>Responsible for regulating neuronal growth in nervous system development and hippocampal formation</li><li>Mutation in FGFR3 is linked with medial temporal lobe dysgenesis and seizures</li></ul><div>miRNA-486-5p</div><ul><li>Targets for GABRB3, which encodes for a subunit of the GABA receptor</li><li>A missense mutation in GABRB3 is observed in multiple neurological disorders including epilepsy</li></ul><div>lnc-KCNH5-1</div><ul><li>Mutations in KCNH5 are correlated with epilepsy and impaired neuronal functions. Hypothetically, as a member of the KCNH5 family, lnc-KCNH5-1 might be involved in relevant neuronal activities.&nbsp;</li></ul><div><br><strong>How are the pathways related to the disease?</strong></div><ul><li>Olfactory transduction: deficiencies are widely found in temporal lobe epilepsy patients due to the spread of neuroinflammation throughout the brain</li><li>Cytokine-cytokine receptor interaction pathway and oxidative phosphorylation pathway are also linked with the occurrence of epilepsy</li><li>One of the pathological changes is found in both Parkinson's disease and hippocampal sclerosis</li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2022-12-02 22:08:16 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407192161</guid>
      </item>
      <item>
         <title>References</title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407197041</link>
         <description><![CDATA[<ol><li>Stafstrom, C.E., <em>et al.</em> Seizures and epilepsy: an overview for neuroscientists. <em>Cold Spring Harb Perspect Med</em>, (2015).</li><li>Wang, Z.-B. <em>et al.</em> Integrated Analysis of expression profile and potential pathogenic mechanism of temporal lobe epilepsy with hippocampal sclerosis. <em>Frontiers in Neuroscience</em> 16, (2022).&nbsp;</li><li>Dupont, C., <em>et al</em>. Epigenetics: definition, mechanisms and clinical perspective. <em>Semin Reprod Med </em>27(5), 351-357 (2009).</li><li>Bernardo, P., <em>et al.</em> Temporal lobe malformations, focal epilepsy, and FGFR3 mutations: a non-causal association?. <em>Neurol Sci</em> 42, 2063–2067 (2021).&nbsp;</li><li>Gorter, J. A., <em>et al. </em>Which insights have we gained from the kindling and post-status epilepticus models?. <em>Journal of Neuroscience Methods</em> 260, 96-108 (2016).</li><li>Reddy, S.D., <em>et al.</em> Epigenetic Histone Deacetylation Inhibition Prevents the Development and Persistence of Temporal Lobe Epilepsy. <em>J Pharmacol Exp Ther. </em>364(1), 97-109 (2018).</li><li>Löscher, W. Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies. <em>Epilepsy Research</em> 126, 157-184 (2016).</li></ol>]]></description>
         <enclosure url="" />
         <pubDate>2022-12-02 22:19:23 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407197041</guid>
      </item>
      <item>
         <title>Proposed Mechanism</title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407373888</link>
         <description><![CDATA[<ul><li>Using this evidence, they hypothesized that the upregulation of lnc-KCNH5-1 reduced the expression of has-miR-486-5p by adsorbing it</li><li>Reduced has-miR-486-5p reduced its repressive effect on FGFR3</li><li>Resulting in the upregulation of FGFR3 expression</li><li>Decreased FGFR3 methylation also contributed to the upregulation of FGFR3 expression</li></ul>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1905527446/8530e816490466711f4ab56c3bacef5d/image.png" />
         <pubDate>2022-12-03 07:13:30 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407373888</guid>
      </item>
      <item>
         <title>Acknowledgements</title>
         <author>jys011006</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407698155</link>
         <description><![CDATA[<div><strong><em>Sam Jose</em></strong>: Title, Background, Goal of Study, Results<br><strong><em>Xiaoting Yuan</em></strong>: Methods, Discussions, Future Directions<br><strong><em>All members</em></strong> contributed to References &amp; Formatting</div>]]></description>
         <enclosure url="" />
         <pubDate>2022-12-03 21:45:45 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407698155</guid>
      </item>
      <item>
         <title></title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407760894</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1905527446/a43991a5ac319144dc25887c9911fbfa/image.png" />
         <pubDate>2022-12-04 02:05:57 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407760894</guid>
      </item>
      <item>
         <title></title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407760979</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1905527446/cf42b654367ae6d7b7b82425b08e615f/image.png" />
         <pubDate>2022-12-04 02:06:16 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407760979</guid>
      </item>
      <item>
         <title></title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407761066</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1905527446/fff822b98d2d27d867470cbefc961e6a/image.png" />
         <pubDate>2022-12-04 02:06:34 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407761066</guid>
      </item>
      <item>
         <title></title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407794309</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1905527446/861c75efa9e80c055d858840e3c461e9/image.png" />
         <pubDate>2022-12-04 04:01:01 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407794309</guid>
      </item>
      <item>
         <title></title>
         <author>samjose1</author>
         <link>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407796159</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1905510589/3e7950d48c47d0837ff2bfa8d8deaa97/FGFR3_protein_structure.jpg" />
         <pubDate>2022-12-04 04:07:27 UTC</pubDate>
         <guid>https://padlet.com/samjose1/lpsmm4b1f1hguug7/wish/2407796159</guid>
      </item>
   </channel>
</rss>
